Vestibular Migraine

Neurology
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Otolith Labs
Otolith LabsDC - Washington
2 programs
Otoband ExperimentalN/A1 trial
Otolith Device ActiveN/A1 trial
Active Trials
NCT06267924CompletedEst. Jan 2025
NCT06540235Active Not RecruitingEst. Nov 2025
HM
Hua MedicineChina - Shanghai
1 program
CGRP R Inhibitor; CGRP InhibitorN/A1 trial
Active Trials
NCT07203248Not Yet Recruiting2,000Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
Hua MedicineCGRP R Inhibitor; CGRP Inhibitor
Otolith LabsOtolith Device Active
Otolith LabsOtoband Experimental

Clinical Trials (3)

Total enrollment: 2,000 patients across 3 trials

NCT07203248Hua MedicineCGRP R Inhibitor; CGRP Inhibitor

Chinese Real-world Study of Treatment of Vestibular Migraine

Start: Dec 2025Est. completion: Dec 20282,000 patients
N/ANot Yet Recruiting
NCT06540235Otolith LabsOtolith Device Active

The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines

Start: Aug 2024Est. completion: Nov 2025
N/AActive Not Recruiting
NCT06267924Otolith LabsOtoband Experimental

SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines

Start: Mar 2024Est. completion: Jan 2025
N/ACompleted

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space